Listed

Bioharvest Sciences Inc.

BHSTNasdaqCIK 1723464HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Balance sheet

Cash and equivalents$23.0m, FY2025
Shareholders' equity$25.4m, FY2025
Line itemUnitperiod not labelled2022-12-31period not labelled2023-12-31FY20242024-12-31FY20252025-12-31
Cash and equivalents$mnot reported5.4Cash and equivalents, period not labelled, at 2023-12-31$5.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 40-F filed 2025-03-31, accession 0001376474-25-000299.Report this figure2.4Cash and equivalents, FY2024, at 2024-12-31$2.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 40-F filed 2026-03-31, accession 0001376474-26-000257.Report this figure23.0Cash and equivalents, FY2025, at 2025-12-31$23.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 40-F filed 2026-03-31, accession 0001376474-26-000257.Report this figure
Current assets$mnot reported9.1Current assets, period not labelled, at 2023-12-31$9.1m. XBRL concept us-gaap:AssetsCurrent. 40-F filed 2025-03-31, accession 0001376474-25-000299.Report this figure7.9Current assets, FY2024, at 2024-12-31$7.9m. XBRL concept us-gaap:AssetsCurrent. 40-F filed 2026-03-31, accession 0001376474-26-000257.Report this figure30.5Current assets, FY2025, at 2025-12-31$30.5m. XBRL concept us-gaap:AssetsCurrent. 40-F filed 2026-03-31, accession 0001376474-26-000257.Report this figure
Total assets$mnot reported15.0Total assets, period not labelled, at 2023-12-31$15.0m. XBRL concept ifrs-full:Assets. 40-F filed 2025-03-31, accession 0001376474-25-000299.Report this figure25.0Total assets, FY2024, at 2024-12-31$25.0m. XBRL concept ifrs-full:Assets. 40-F filed 2026-03-31, accession 0001376474-26-000257.Report this figure47.7Total assets, FY2025, at 2025-12-31$47.7m. XBRL concept ifrs-full:Assets. 40-F filed 2026-03-31, accession 0001376474-26-000257.Report this figure
Current liabilities$mnot reported26.5Current liabilities, period not labelled, at 2023-12-31$26.5m. XBRL concept us-gaap:LiabilitiesCurrent. 40-F filed 2025-03-31, accession 0001376474-25-000299.Report this figure14.3Current liabilities, FY2024, at 2024-12-31$14.3m. XBRL concept us-gaap:LiabilitiesCurrent. 40-F filed 2026-03-31, accession 0001376474-26-000257.Report this figure7.7Current liabilities, FY2025, at 2025-12-31$7.7m. XBRL concept us-gaap:LiabilitiesCurrent. 40-F filed 2026-03-31, accession 0001376474-26-000257.Report this figure
Short-term borrowings$mnot reported0.0Short-term borrowings, period not labelled, at 2023-12-31$0. XBRL concept us-gaap:ShortTermBorrowings. 40-F filed 2025-03-31, accession 0001376474-25-000299.Report this figure3.9Short-term borrowings, FY2024, at 2024-12-31$3.9m. XBRL concept us-gaap:ShortTermBorrowings. 40-F filed 2026-03-31, accession 0001376474-26-000257.Report this figure0.1Short-term borrowings, FY2025, at 2025-12-31$149.0k. XBRL concept us-gaap:ShortTermBorrowings. 40-F filed 2026-03-31, accession 0001376474-26-000257.Report this figure
Shareholders' equity$m(5.9)Shareholders' equity, period not labelled, at 2022-12-31−$5.9m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 40-F filed 2025-03-31, accession 0001376474-25-000299.Report this figure(14.9)Shareholders' equity, period not labelled, at 2023-12-31−$14.9m. XBRL concept us-gaap:StockholdersEquity. 40-F filed 2025-03-31, accession 0001376474-25-000299.Report this figure1.3Shareholders' equity, FY2024, at 2024-12-31$1.3m. XBRL concept us-gaap:StockholdersEquity. 40-F filed 2026-03-31, accession 0001376474-26-000257.Report this figure25.4Shareholders' equity, FY2025, at 2025-12-31$25.4m. XBRL concept us-gaap:StockholdersEquity. 40-F filed 2026-03-31, accession 0001376474-26-000257.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.